08.02.2022 - MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) - Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) in collaboration with Kanazawa University today announces that the Phase I clinical study of its investigational .
Japanese Prostate Cancer Imaging Trial Meets Study Objectives GlobeNewswire February 07, 2022 MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) in collaboration with Kanazawa University today announces that the Phase I clinical study of its investigational prostate cancer imaging product in.
IPS cells show therapeutic benefits for rare muscle dystrophy miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.